Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABT

Abundant Produce (ABT)

Abundant Produce Limited
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:ABT
DateTimeSourceHeadlineSymbolCompany
06/10/200912:11PMDow Jones NewsAbbott CEO: No Interest In Large, 'Mega-Deal' MergersNYSE:ABTAbbott Laboratories
06/09/20091:09PMDow Jones NewsSuccessful TriLipix Trials Good News For Solvay - AnalystsNYSE:ABTAbbott Laboratories
06/09/200911:30AMDow Jones NewsIN THE PIPELINE: Less Is More In Boston Sci Stent PlansNYSE:ABTAbbott Laboratories
06/07/20096:41PMDow Jones NewsCORRECT: Large Study Questions Value Of StentsNYSE:ABTAbbott Laboratories
06/07/20096:33PMDow Jones NewsUPDATE: Large Study Questions Value Of StentsNYSE:ABTAbbott Laboratories
06/07/20096:03PMDow Jones NewsLarge Study Questions Value Of StentsNYSE:ABTAbbott Laboratories
06/04/20098:20AMDow Jones NewsAstraZeneca, Abbott Submitted New Drug Application To The FDANYSE:ABTAbbott Laboratories
05/29/200911:08AMDow Jones NewsFDA:Advanced Life's Restanza Has No Unexpected Side EffectsNYSE:ABTAbbott Laboratories
05/26/200912:34PMDow Jones NewsAbbott Heart Drug Faces Key Test In Large US StudyNYSE:ABTAbbott Laboratories
05/22/20094:34PMDow Jones NewsDrug Makers To Pay $89 Million To Settle Alabama Medicaid Price SuitsNYSE:ABTAbbott Laboratories
05/22/20094:34PMDow Jones NewsFDA: Doctors Must Tell People About Lasik Eye Surgery RisksNYSE:ABTAbbott Laboratories
05/21/20097:00PMDow Jones NewsFenofibrate Cuts Amputation Risk For Type 2 Diabetics -StudyNYSE:ABTAbbott Laboratories
05/21/20099:30AMDow Jones NewsAbbott: Low Event Rates In Big One-Year Stent StudyNYSE:ABTAbbott Laboratories
05/19/20092:45PMDow Jones NewsUPDATE: J&J: New Stent Outperforms Rival Device In TrialNYSE:ABTAbbott Laboratories
05/19/200910:05AMDow Jones NewsJ&J: New 'Nevo' Stent Outperforms Rival Device In TrialNYSE:ABTAbbott Laboratories
05/07/20091:08PMDow Jones NewsHealth-Care Stocks Rally On Hopes For Bipartisan ReformNYSE:ABTAbbott Laboratories
05/06/200912:22PMDow Jones NewsAbbott Files Patent-Infringement Suit Vs. J&J Over SimponiNYSE:ABTAbbott Laboratories
05/04/200911:59AMDow Jones NewsMedicare Changes Benign For Device Cos, But Pressure LoomsNYSE:ABTAbbott Laboratories
04/23/20097:06PMDow Jones News2nd UPDATE: Amgen 1Q Profit Drops 7.4%; Cuts '09 Revenue ViewNYSE:ABTAbbott Laboratories
04/23/20096:23PMDow Jones NewsUPDATE: Amgen 1Q Profit Drops 7.4%; Cuts '09 Revenue ViewNYSE:ABTAbbott Laboratories
04/22/20094:56PMDow Jones NewsSome Makers Of Coated Heart Stents Report Lowering US PricesNYSE:ABTAbbott Laboratories
04/22/20094:30PMDow Jones NewsUS Drug Market To Shrink In 2009, Global Growth Slowing -IMSNYSE:ABTAbbott Laboratories
04/21/20094:52PMDow Jones NewsTrial In Employee Suit Against Abbott, Hospira To Start WedNYSE:ABTAbbott Laboratories
04/21/200910:20AMDow Jones NewsBoston Sci Sets 2Q Sales Targets For Stents, ICDsNYSE:ABTAbbott Laboratories
04/16/20094:21PMDow Jones NewsDEALWATCH: Dull Pharma JV May Become Alluring Spin-Off, SaleNYSE:ABTAbbott Laboratories
04/15/200911:47AMDow Jones News2nd UPDATE: Abbott Labs 1Q Net Up 53% On JV Gain Despite Weak SalesNYSE:ABTAbbott Laboratories
04/15/200911:08AMDow Jones NewsUPDATE: Abbott Labs CEO: Not Evaluating Any Large DealsNYSE:ABTAbbott Laboratories
04/15/200911:07AMDow Jones NewsCORRECT: UPDATE: Abbott Labs 1Q Net Up 53% On JV Gain Despite Weak SalesNYSE:ABTAbbott Laboratories
04/15/200910:29AMDow Jones NewsAbbott Labs CEO: Not Evaluating Any Large DealsNYSE:ABTAbbott Laboratories
04/15/20099:51AMDow Jones NewsUPDATE: Abbott Labs 1Q Net Up 53% On JV Gain Despite Weak SalesNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:ASX:ABT